SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-303848
Filing Date
2014-08-11
Accepted
2014-08-11 07:26:59
Documents
12
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d739790d10q.htm 10-Q 649996
2 EX-31.1 d739790dex311.htm EX-31.1 9129
3 EX-31.2 d739790dex312.htm EX-31.2 9145
4 EX-32.1 d739790dex321.htm EX-32.1 6024
5 EX-99.1 d739790dex991.htm EX-99.1 42606
12 GRAPHIC g7397901.jpg GRAPHIC 8551
  Complete submission text file 0001193125-14-303848.txt   5004030

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT akba-20140630.xml EX-101.INS 691372
7 XBRL TAXONOMY EXTENSION SCHEMA akba-20140630.xsd EX-101.SCH 42284
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE akba-20140630_cal.xml EX-101.CAL 65328
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE akba-20140630_def.xml EX-101.DEF 170405
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE akba-20140630_lab.xml EX-101.LAB 342664
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akba-20140630_pre.xml EX-101.PRE 263414
Mailing Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36352 | Film No.: 141028931
SIC: 2834 Pharmaceutical Preparations